1. Home
  2. PBH vs AUPH Comparison

PBH vs AUPH Comparison

Compare PBH & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

N/A

Current Price

$42.87

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$16.41

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBH
AUPH
Founded
1996
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
PBH
AUPH
Price
$42.87
$16.41
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
★ $67.80
$18.29
AVG Volume (30 Days)
512.0K
★ 862.5K
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.14
0.76
Revenue
★ $975,777,000.00
$283,055,000.00
Revenue This Year
$19.22
$16.65
Revenue Next Year
$6.35
$17.73
P/E Ratio
$46.74
★ $22.51
Revenue Growth
★ 36.77
N/A
52 Week Low
$42.62
$13.52
52 Week High
$71.07
$19.25

Technical Indicators

Market Signals
Indicator
PBH
AUPH
Relative Strength Index (RSI) 37.80 47.46
Support Level N/A $15.61
Resistance Level $50.26 $16.48
Average True Range (ATR) 1.95 0.55
MACD -0.38 -0.08
Stochastic Oscillator 15.39 28.13

Price Performance

Historical Comparison
PBH
AUPH

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: